🤯 Have you seen our AI stock pickers’ 2024 results? 84.62%! Grab November’s list now.Pick Stocks with AI

Omnicom To Acquire Elsevier's Pharma Communications In Japan

Published 03/27/2018, 10:50 PM
Updated 07/09/2023, 06:31 AM
IPG
-
OMC
-
EMC_old
-
ADP
-
RELX
-

Omnicom Health Group, a division of Omnicom Group Inc. (NYSE:OMC) , announced that it has inked a definitive agreement to acquire Elsevier's Pharma Communications business, which is part of the RELX Group, RELX PLC (NYSE:RELX) , for an undisclosed amount.

The acquired business has been a leading healthcare communications business in Japan for 38 years. It enjoys a reputation for quality delivery of medical content for promotional materials and educational programs directed at doctors and patients.

The acquired business and employees will become part of the newly named healthcare marketing communications agency, EMC (NYSE:EMC) K.K. The acquired unit's management team will also join EMC while Takao Ozawa will be the Managing Director. He will report to David Stark, CEO of Omnicom Health Group Asia Pacific (OHG AP).

EMC further strengthens OHG's roster of leading healthcare agencies in Japan, including Targis, Rx Healthcare, Polaris Consumer Health, CDM Tokyo and MCI.

Having a solid credibility, OHG will get an opportunity to expand its business in Japan, which is the world’s second largest pharmaceutical market. Also, the addition of EMC's talented healthcare specialists and their long-term good standing in the market will add value to OHG services and enable the company to meet growing client demand and maintain the best service offering in Japan.

With EMC, OHG will have unmatched scale, depth and breadth of dedicated healthcare communications services. The transaction is expected to close in the second quarter of 2018, subject to customary closing conditions.

Omnicom continues to expand its global footprint and explore new service areas. It is also building upon its digital and analytical capabilities by investing in agencies and partnering with innovative technology companies in key markets. The company is currently concentrating on strengthening its business while expanding client base globally. The company maintains a balanced growth model through a combination of well-focused internal development initiatives and strategic acquisitions. We expect the company to witness higher revenues in the future on the back of its focused growth initiatives.

The stock has outperformed the industry in the last three months with an average loss of 0.2% compared with a decline of 5.5% for the latter.



Zacks Rank and Stocks to Consider

Omnicom carries a Zacks Rank #3 (Hold). Some better-ranked stocks in the broader industry are The Interpublic Group of Companies, Inc. (NYSE:IPG) and Automatic Data Processing, Inc. (NASDAQ:ADP) , both carrying a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Interpublic has an expected long-term earnings growth rate of 6.7%. It exceeded earnings estimates twice in the trailing four quarters, with an average of 31.5%.

Automatic Data Processing has an expected long-term earnings growth rate of 11%. It surpassed earnings estimates thrice in the trailing four quarters, the average being 5.5%.

Will You Make a Fortune on the Shift to Electric Cars?

Here's another stock idea to consider. Much like petroleum 150 years ago, lithium power may soon shake the world, creating millionaires and reshaping geo-politics. Soon electric vehicles (EVs) may be cheaper than gas guzzlers. Some are already reaching 265 miles on a single charge.

With battery prices plummeting and charging stations set to multiply, one company stands out as the #1 stock to buy according to Zacks research.

It's not the one you think.

See This Ticker Free >>

RELX PLC (RELX): Free Stock Analysis Report

Omnicom Group Inc. (OMC): Free Stock Analysis Report

Interpublic Group of Companies, Inc. (The) (IPG): Free Stock Analysis Report

Automatic Data Processing, Inc. (ADP): Free Stock Analysis Report

Original post

Zacks Investment Research

Latest comments

Loading next article…
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.